Alexander Hardy - Mar 14, 2025 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: Chief Executive Officer, Director
Signature: /s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol: BMRN
Transactions as of: Mar 14, 2025
Transactions value $: -$203,668
Form type: 4
Date filed: 3/18/2025, 06:17 PM
Previous filing: Dec 3, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Tax liability	-$204K	-2.93K	-2.19%	$69.44	131K	Mar 14, 2025	Direct
transaction	BMRN	Common Stock	Award	$0	+44.4K	+33.81%	$0.00	176K	Mar 17, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to Buy Common Stock)	Award	$0	+61.8K		$0.00	61.8K	Mar 17, 2025	Common Stock	61.8K	$71.55	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted March 17, 2025. Price not applicable.
F2	Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter.